Fisher Wallace Laboratories

Medical Devices for Mood and Sleep

Claim My Business
Security Type
Common Stock
Min Investment
Offering Date
October 07, 2019
Expected Close Date
July 02, 2024
Target Raise
No. Investors
Security Price
Deal Notes

Security Name: Class B Non-Voting Stock

$2.50 per share

Number of Employees
Short Term Debt
Cost of Goods
Long Term Debt
Net Income

Company Description

Fisher Wallace manufactures and markets wearable medical devices for the treatment of depression, anxiety and insomnia.


$1500+ | 42% discount on the purchase of a Fisher Wallace device $5,000+ | Above + 2% bonus shares $10,000+ | Above + 3% bonus shares $20,000+ | Above + 5% bonus shares

Key Deal Facts

An FDA-Cleared, clinically validated solution for depression, anxiety and insomnia with over 50,000 patients and 10,000 prescribers in the United States $4.7 Million net revenue in 2018 with total lifetime revenue of $23.3 Million Named an INC 5000 fastest growing company with OTC approval in Europe, Canada, Mexico and Brazil, and recently obtained Medicaid approval in Maine (MaineCare)

Use of Proceeds

StartEngine Platform Fees: 3.5%, 

Marketing: 50.5%, 

Research & Development: 46.0

Management Team / Advisory Board Bios

Kelly Roman Co-Founder & CEO & Director For the past decade, Kelly Roman has helped lead the fields of neuromodulation product development, regulatory affairs, healthcare marketing and clinical trial strategy. Prior to co-founding Fisher Wallace, Kelly graduated from Harvard and served as an award-winning executive in the digital advertising and SaaS industries. He currently serves on the boards of two charter high schools in New York City. Charles Fisher Co-Founder & Chairman & Director Charles “Chip” Fisher grew up in the electronics business before helping pioneer the neuromodulation industry - his father, Avery Fisher, founded Fisher Radio (later named Fisher Electronics). After graduating from Harvard and serving as a sales executive at IBM, Chip acquired the original intellectual property to the Fisher Wallace Stimulator and is the company’s largest shareholder - and recent TEDx contributor.

Deal Notes

Security Name: Class B Non-Voting Stock

$2.50 per share

Amount Raised : $526,627
Reveal the Score by Voting
Additional ratings from other users are needed to determine a viable CrowdScore for this deal.
The "CrowdScore" for this deal is determined by user ratings and other factors using our proprietary algorithm.
The overall viability and scalability of the business concept as well as the ability to drive the concept to profitability over time.
Business Idea
The progress made thus far in demonstrating that the business has viability, a customer base or other business traction.
Business Traction
The experience of the management team in running, scaling and/or exiting a business that required similar skills to execute the business plan.
Management Team
The value of the company compared to similar companies raising money from investors.

Security Description

Common stock is a security that represents ownership in a corporation.

Research Reports

No reports have been submitted

Become a Reporter